-+ 0.00%
-+ 0.00%
-+ 0.00%

TANDEM DIABETES CARE, INC. : OPPENHEIMER CUTS TARGET PRICE TO $22 FROM $44

Reuters·09/08/2025 12:51:39

Please log in to view news